<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00285909</url>
  </required_header>
  <id_info>
    <org_study_id>P6689</org_study_id>
    <secondary_id>Alcohol research 20</secondary_id>
    <nct_id>NCT00285909</nct_id>
  </id_info>
  <brief_title>Moderate Alcohol Consumption, Risk of Cardiovascular Disease and Type 2 Diabetes: Influence of Alcohol Oxidation</brief_title>
  <official_title>Effect of Moderate Alcohol Consumption on PPAR-γ Activity and Risk Markers of Metabolic Disease: Influence of Genetic Variation in Alcohol Oxidation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TNO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TNO</source>
  <brief_summary>
    <textblock>
      Moderate alcohol consumption is associated with a decreased risk of cardiovascular disease&#xD;
      and type 2 diabetes. The association of alcohol consumption with cardiovascular disease is&#xD;
      mediated by a functional polymorphism of alcohol dehydrogenase 1c, but the effect of this&#xD;
      polymorphism on alcohol metabolism is only investigated in vitro.&#xD;
&#xD;
      The risk reduction of moderate alcohol consumption for cardiovascular disease is explained&#xD;
      largely by an increase of HDL cholesterol, but an increase of adiponectin concentrations&#xD;
      after moderate alcohol consumption may also be involved. It seems likely that adiponectin is&#xD;
      a mediator for the association of moderate alcohol consumption with type 2 diabetes. The&#xD;
      mechanism by which moderate alcohol consumption increases adiponectin concentrations is&#xD;
      unknown, but ppar-gamma activation may be involved.&#xD;
&#xD;
      effects of this polymorphism on mediators of this relation are not known. This study&#xD;
      therefore investigates the effect of moderate alcohol consumption and the influence of&#xD;
      alcohol dehydrogenase 1c polymorphism on ppar-gamma activated gene expression and risk&#xD;
      factors of cardiovascular disease and type 2 diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives :&#xD;
&#xD;
      To investigate the effect of moderate alcohol consumption and influence of genetic variation&#xD;
      of ethanol oxidation on:&#xD;
&#xD;
        -  PPAR-γ activated gene expression&#xD;
&#xD;
        -  Markers of coronary heart disease or type 2 diabetes&#xD;
&#xD;
        -  Postprandial changes of HPA-axis activity among 36 postmenopausal women with ADH1C&#xD;
           genotype associated with slow or fast alcohol metabolism.&#xD;
&#xD;
      Design : Randomized, controlled, not blinded crossover trial with 1 week wash-out preceding&#xD;
      each treatment period&#xD;
&#xD;
      Participants&#xD;
&#xD;
        -  Description : Apparently healthy postmenopausal women&#xD;
&#xD;
        -  Number : 36&#xD;
&#xD;
      Study substances&#xD;
&#xD;
        -  Test substance : White wine (ca. 25 g alcohol/day)&#xD;
&#xD;
        -  Reference substance : White grape juice&#xD;
&#xD;
      Study treatments Treatment A: 250 ml white wine daily (ca. 25 g alcohol/day) Treatment B: 250&#xD;
      ml white grape juice daily&#xD;
&#xD;
      Study period&#xD;
&#xD;
      - Duration : two periods of 6 weeks preceded by 1 week wash-out period&#xD;
&#xD;
      Test parameters:&#xD;
&#xD;
        -  Adiponectin mRNA expression&#xD;
&#xD;
        -  Expression of PPAR-gamma activated genes: CD36, lipoprotein lipase, AP2&#xD;
&#xD;
        -  Markers of cardiovascular disease (blood lipid profile, Lp-PLA2 activity, hs-CRP,&#xD;
           fibrinogen)&#xD;
&#xD;
        -  Markers of type 2 diabetes (adiponectin, adiponectin oligomers, insulin sensitivity)&#xD;
&#xD;
        -  Parameters of alcohol oxidation (postprandial: blood alcohol and acetate, acetaldehyde)&#xD;
&#xD;
        -  HPA-axis activity (postprandial &amp; fasting: cortisol, ACTH, testosterone)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date>June 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PPAR-gamma activated gene expression</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors of cardiovascular disease and type 2 diabetes</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial changes of HPA-axis activity</measure>
  </secondary_outcome>
  <enrollment>36</enrollment>
  <condition>Cardiovascular Disease</condition>
  <condition>Type 2 Diabetes</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Alcohol: 25 gday (white wine)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy women aged 40 to 65 years&#xD;
&#xD;
          -  Absence of menstrual period for at least 2 years&#xD;
&#xD;
          -  Homozygotes for the ADH1C*1 or ADH1C*2 allele of ADH1C I349V polymorphism&#xD;
&#xD;
          -  Alcohol consumption ≥ 5 and ≤ 21 units/week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Family history of alcoholism&#xD;
&#xD;
          -  History of medical or surgical events that may significantly affect the study outcome,&#xD;
             particularly metabolic or endocrine disorders and gastrointestinal disorders&#xD;
&#xD;
          -  Recent blood donation&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henk FJ Hendriks, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>TNO</affiliation>
  </overall_official>
  <verification_date>August 2006</verification_date>
  <study_first_submitted>January 31, 2006</study_first_submitted>
  <study_first_submitted_qc>January 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2006</study_first_posted>
  <last_update_submitted>August 15, 2006</last_update_submitted>
  <last_update_submitted_qc>August 15, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2006</last_update_posted>
  <keyword>Moderate alcohol consumption</keyword>
  <keyword>Alcohol dehydrogenase 1c polymorphism</keyword>
  <keyword>PPAR-gamma activated gene expression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

